DB17250Experimental
MDX-210: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Receptor tyrosine-protein kinase erbB-2 and High affinity immunoglobulin gamma Fc receptor I
- Also known as
- Bispecific antibody 520c9x22 · BsAb 520C9x22 · BsAb 520C9xH22
- Code names
- MDX-H210
Resolves to
Targets
What you can answer from here — as of June 15, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with MDX-210, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account